♀️
Ovarian & Women's Cancers
Our women's cancer program addresses ovarian, cervical, and endometrial cancers through innovative early-detection methods and PARP-inhibitor–based therapies.
Learn More5,000+
Women screened annually
1,800+
BRCA testing completed
22%
Early-stage detection rate improvement
Research Themes
1
BRCA & HRD-Directed Therapy
Optimizing PARP inhibitor maintenance strategies based on homologous recombination deficiency status in ovarian cancer.
2
Multi-Cancer Early Detection
Developing and validating cfDNA-based tests for simultaneous detection of ovarian, endometrial, and cervical cancers.
3
Cervical Cancer Elimination
HPV vaccination awareness programs and clinical trials of therapeutic HPV vaccines for pre-invasive disease.
Clinical Trials
NCT06234512
RecruitingNiraparib + Bevacizumab Maintenance in Advanced Ovarian Cancer
PI: Dr. Rama Jayaraj
NCT06234513
ActiveTherapeutic HPV Vaccine in High-Grade Cervical Intraepithelial Neoplasia
PI: Dr. Shirley Sunder Singh
Champion Women's Cancer Research
Donations fund early detection research and clinical trials that give women diagnosed with ovarian and cervical cancers access to the most promising new therapies.
Donate Now